Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC -0.22 4e-05
mRNA Docetaxel gCSI pan-cancer AAC -0.2 0.0001
mRNA Doxorubicin gCSI pan-cancer AAC -0.19 0.0002
mRNA paclitaxel gCSI pan-cancer AAC -0.19 0.0003
mRNA thapsigargin gCSI pan-cancer AAC -0.19 0.0006
mRNA TKI258 CCLE pan-cancer AAC -0.15 0.0009
mRNA paclitaxel UHNBreast pan-cancer AAC -0.82 0.001
mRNA Irinotecan gCSI pan-cancer AAC -0.17 0.001
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.11 0.002
Download CSV